Skip to Content

M E 31 (Erlotinib Hydrochloride 25 mg)

Pill with imprint M E 31 is White, Round and has been identified as Erlotinib Hydrochloride 25 mg.

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M E 31

Erlotinib hydrochloride 25 mg M E 31

Erlotinib Hydrochloride

Imprint
M E 31
Strength
25 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Manufacturer
Mylan Pharmaceuticals Inc
National Drug Code (NDC)
00378-7131

Get help with Imprint Code FAQs.

Related Images for "M E 31"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.